Viekira Pak — Medica
Chronic Hepatitis C Virus (HCV), Genotype 1a
Initial criteria
- age ≥ 18 years
- Patient does not have cirrhosis OR patient has cirrhosis
- The medication is prescribed in combination with ribavirin
- The medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or a liver transplant physician
Reauthorization criteria
- Patient has been started on Viekira Pak and needs remaining duration to complete course of therapy
Approval duration
12 weeks without cirrhosis OR 24 weeks with cirrhosis